Perspecta (PRSP) stock price, revenue, and financials

Perspecta market cap is $4.3 b, and annual revenue was $4.50 b in FY 2020

-0.07 (-0.26%)

$4.3 B

PRSP Mkt cap, 25-Jan-2021

Perspecta Revenue Q2, 2021

Perspecta Gross profit (Q2, 2021)230 M

Perspecta Gross profit margin (Q2, 2021), %20.1%

Perspecta Net income (Q2, 2021)16 M

Perspecta Cash, 02-Oct-2020216 M

Perspecta EV6.7 B

Perspecta revenue was $4.50 b in FY, 2020 which is a 11.8% year over year increase from the previous period.

Embed Graph

Embed Graph

Perspecta revenue breakdown by business segment: 68.8% from Defense and Intelligence and 31.2% from Civilian and Health Care

USD	FY, 2018	FY, 2019	FY, 2020
Revenue	2.8b	4.0b	4.5b
Revenue growth, %		43%	12%
Cost of goods sold	2.2b	3.0b	3.5b
Gross profit	664.0m	987.0m	1.0b
Gross profit Margin, %	24%	24%	23%
General and administrative expense	182.0m	300.0m	303.0m
Operating expense total	453.0m	754.0m	1.6b
Depreciation and amortization	167.0m	330.0m	374.0m
Interest expense	12.0m	121.0m	137.0m
Pre tax profit	199.0m	112.0m	(730.0m)
Income tax expense	(9.0m)	40.0m	(54.0m)
Net Income	208.0m	72.0m	(676.0m)
EPS	1.5	0.4	(4.2)

USD	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021
Revenue	793.0m	1.1b	1.1b	1.1b	1.2b	1.1b	1.1b	1.1b
Cost of goods sold	597.0m	813.0m	816.0m	836.0m	908.0m	863.0m	899.0m	912.0m
Gross profit	196.0m	255.0m	259.0m	271.0m	264.0m	263.0m	209.0m	230.0m
Gross profit Margin, %	25%	24%	24%	24%	23%	23%	19%	20%
General and administrative expense	61.0m	89.0m	76.0m	72.0m	81.0m	77.0m	62.0m	65.0m
Operating expense total	145.0m	182.0m	174.0m	194.0m	191.0m	154.0m	176.0m	182.0m
Depreciation and amortization	64.0m	74.0m	76.0m	101.0m	90.0m	92.0m	96.0m	96.0m
Interest expense	10.0m	37.0m	37.0m	35.0m	36.0m	34.0m	30.0m	29.0m
Pre tax profit	41.0m	36.0m	48.0m	42.0m	37.0m	75.0m	3.0m	19.0m
Income tax expense	12.0m	12.0m	10.0m	11.0m	8.0m	22.0m	6.0m	3.0m
Net Income	29.0m	24.0m	38.0m	31.0m	29.0m	53.0m	(3.0m)	16.0m
EPS	0.2	0.1	0.2	0.2	0.2	0.3	0.0	0.1

USD	FY, 2018	FY, 2019	FY, 2020
Cash		88.0m	147.0m
Accounts Receivable	354.0m	484.0m	513.0m
Prepaid Expenses	74.0m	141.0m	81.0m
Current Assets	449.0m	878.0m	887.0m
PP&E	290.0m	368.0m	307.0m
Goodwill	2.0b	3.2b	2.7b
Total Assets	3.7b	6.1b	5.4b
Accounts Payable	195.0m	246.0m	218.0m
Short-term debt	160.0m	217.0m	239.0m
Current Liabilities	605.0m	1.0b	1.1b
Long-term debt	144.0m	2.5b	2.4b
Total Debt	304.0m	2.7b	2.7b
Total Liabilities	950.0m	3.9b	4.0b
Common Stock		2.0m	2.0m
Additional Paid-in Capital		2.2b	2.3b
Retained Earnings		2.0m	(713.0m)
Total Equity	2.7b	2.2b	1.4b
Debt to Equity Ratio	0.1 x	1.2 x	2 x
Debt to Assets Ratio	0.1 x	0.4 x	0.5 x
Financial Leverage	1.3 x	2.8 x	4 x

USD	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021
Cash	201.0m	126.0m	100.0m	179.0m	122.0m	69.0m	122.0m	216.0m
Accounts Receivable	508.0m	535.0m	487.0m	480.0m	570.0m	526.0m	566.0m	520.0m
Prepaid Expenses	116.0m	173.0m	158.0m	111.0m	102.0m	115.0m	62.0m	68.0m
Current Assets	1.0b	1.0b	843.0m	895.0m	934.0m	844.0m	861.0m	910.0m
PP&E	342.0m	363.0m	354.0m	350.0m	333.0m	326.0m	299.0m	278.0m
Goodwill	3.3b	3.3b	3.3b	3.2b	3.3b	3.3b	2.7b	2.7b
Total Assets	6.3b	6.3b	6.1b	6.1b	6.3b	6.2b	5.3b	5.3b
Accounts Payable	206.0m	245.0m	268.0m	242.0m	285.0m	206.0m	158.0m	187.0m
Short-term debt	244.0m	226.0m	219.0m	265.0m	246.0m	245.0m	233.0m	220.0m
Current Liabilities	1.2b	1.2b	1.0b	1.0b	1.1b	1.0b	1.1b	1.1b
Long-term debt	2.6b	2.6b	2.5b	2.4b	2.6b	2.4b	2.5b	2.4b
Total Debt	2.8b	2.8b	2.8b	2.7b	2.8b	2.7b	2.7b	2.7b
Total Liabilities	4.1b	4.1b	3.9b	4.0b	4.2b	4.0b	4.0b	3.9b
Common Stock	2.0m	2.0m	2.0m	2.0m	2.0m	2.0m	2.0m	2.0m
Additional Paid-in Capital	2.2b	2.2b	2.2b	2.2b	2.3b	2.3b	2.3b	2.3b
Retained Earnings	(20.0m)		29.0m	23.0m	42.0m	85.0m	(716.0m)	(700.0m)
Total Equity	2.2b	2.2b	2.2b	2.2b	2.2b	2.2b	1.3b	1.4b
Debt to Equity Ratio	1.3 x	1.3 x	1.3 x	1.3 x	1.3 x	1.2 x	2 x	1.9 x
Debt to Assets Ratio	0.4 x	0.4 x	0.5 x	0.4 x	0.5 x	0.4 x	0.5 x	0.5 x
Financial Leverage	2.9 x	2.9 x	2.8 x	2.8 x	2.9 x	2.8 x	4 x	3.9 x

USD	FY, 2018	FY, 2019	FY, 2020
Net Income	208.0m	72.0m	(676.0m)
Depreciation and Amortization	167.0m	330.0m	374.0m
Accounts Receivable	49.0m	102.0m	97.0m
Accounts Payable	113.0m	(18.0m)	14.0m
Cash From Operating Activities	530.0m	462.0m	626.0m
Purchases of PP&E	(18.0m)	(26.0m)	(17.0m)
Cash From Investing Activities	(34.0m)	(1.3b)	(210.0m)
Short-term Borrowings		(50.0m)	(150.0m)
Long-term Borrowings	(157.0m)	(342.0m)	(234.0m)
Dividends Paid		(1.0b)	(38.0m)
Cash From Financing Activities	(496.0m)	955.0m	(294.0m)
Net Change in Cash		99.0m	122.0m
Interest Paid	19.0m	115.0m	127.0m
Income Taxes Paid	11.0m	61.0m	32.0m

USD	Q1, 2019	Q2, 2019	Q3, 2019	Q1, 2020	Q2, 2020	Q3, 2020	Q1, 2021	Q2, 2021
Net Income	29.0m	53.0m	91.0m	31.0m	60.0m	113.0m	(3.0m)	13.0m
Depreciation and Amortization	64.0m	138.0m	214.0m	101.0m	191.0m	283.0m	96.0m	192.0m
Accounts Receivable	24.0m	(4.0m)	78.0m	55.0m	50.0m	49.0m	(18.0m)	25.0m
Accounts Payable	72.0m	92.0m	(23.0m)	(26.0m)	(16.0m)	(20.0m)	38.0m	37.0m
Cash From Operating Activities	160.0m	236.0m	294.0m	185.0m	320.0m	440.0m	132.0m	296.0m
Purchases of PP&E	(6.0m)	(11.0m)	(12.0m)	(1.0m)	(4.0m)	(11.0m)	(15.0m)	(26.0m)
Cash From Investing Activities	(1.3b)	(1.3b)	(1.3b)	(2.0m)	(272.0m)	(203.0m)	(59.0m)	(700.0m)
Short-term Borrowings	(50.0m)	(50.0m)	(50.0m)			(125.0m)	(50.0m)	(50.0m)
Long-term Borrowings	(41.0m)	(132.0m)	(206.0m)	(57.0m)	(122.0m)	(179.0m)	(54.0m)	(119.0m)
Dividends Paid	(984.0m)	(992.0m)	(1.0b)	(8.0m)	(18.0m)	(28.0m)	(10.0m)	(21.0m)
Cash From Financing Activities	1.3b	1.2b	1.1b	(80.0m)		(208.0m)	(116.0m)	(192.0m)
Net Change in Cash	214.0m	161.0m	109.0m	103.0m	48.0m	29.0m	(43.0m)	34.0m
Interest Paid	8.0m	33.0m	84.0m	32.0m	64.0m	97.0m	28.0m	54.0m
Income Taxes Paid	4.0m	19.0m	25.0m	(3.0m)	12.0m	11.0m		17.0m

Perspecta's Backlog was reported to be $13.9b in Q2, 2021.

	FY, 2018	Q1, 2019	Q2, 2019	Q3, 2019	FY, 2019	Q1, 2020	Q2, 2020	Q3, 2020	FY, 2020	Q1, 2021	Q2, 2021
Backlog		$8.99 b	$10.17 b	$10.43 b	$10.68 b	$10.42 b	$12.70 b	$13.25 b	$13.35 b	$13.52 b	$13.89 b
Backlog (Defense and Intelligence)		$1.98 b	$2 b	$1.41 b	$6.64 b	$1.99 b	$1.97 b	$8.06 b	$8.34 b	$8.46 b	$8.59 b
Backlog (Civilian and Health Care)		$7.01 b	$8.17 b	$326 m	$4.04 b	$8.53 b	$10.74 b	$5.16 b	$5.01 b	$5.07 b	$5.31 b
Contract Awards		$1.32 b	$2.36 b	$1.73 b	$6.80 b	$1 b	$2.31 b	$1.61 b	$6.09 b	$1.18 b	$1.77 b
Contract Awards (Defense and Intelligence)		$345 m	$1.70 b	$1.40 b	$4.70 b	$669 m	$1.93 b	$515 m	$3.78 b	$863 m	$1.02 b
Contracts Awards (Civilian and Health Care)		$975 m	$664 m	$326 m	$2.10 b	$332 m	$372 m	$1.10 b	$2.31 b	$313 m	$751 m
Remaining Performance Obligations					$3.60 b				$3.84 b
Patents Issued									270
New Patents					17
Facility Space, sq. ft.	1.80 m				2.70 m				2.70 m
New Government-Funded Research Projects Launched					18
Medicare Insurance Claims Processed					665 m
Office 365 Mailbox Migrations					90 k
Interfaces Created					19
Unauthorized Intrusion Attempts Prevented per Year					2.50 b				2.50 b
Threats Detected					300 m				300 m